Gilead's three-drug HIV regimen wins European panel approval Ruby Khatun Khatun29 April 2018 10:00 AM ISTGilead Sciences Inc said its three-drug regimen to treat HIV infection was recommended for approval by a panel of the European Medicines Agency,...
Allergan migraine drug succeeds in second late-stage trial Ruby Khatun Khatun29 April 2018 9:45 AM ISTNEW YORK: Allergan Plc announced positive results from a second Phase III trial for the 50-milligram dose of its drug for acute migraine, reproducing...
AbbVie's beat fueled by demand for Humira, Hep C drugs Ruby Khatun Khatun29 April 2018 9:30 AM ISTAbbVie Inc reported a better-than-expected quarterly profit, on higher sales of its rheumatoid arthritis treatment Humira and its Hepatitis C drugs,...
Biocon Q4 net profit up 2 percent at Rs 130 crore; FY18 net dips 39 percent Ruby Khatun Khatun28 April 2018 10:30 AM ISTNew Delhi: Biotechnology major Biocon posted 2 percent increase in its consolidated net profit at Rs 130 crore for the fourth quarter ended March of...
MES Launches YO Home Sperm Test in India Ruby Khatun Khatun28 April 2018 10:00 AM ISTMumbai: Medical Electronic Systems (MES), a Los Angeles based technology company specializing in rapid Automated Semen Analysis, announced the launch...
UK healthcare startup Cera is said to have posted fake reviews Ruby Khatun Khatun28 April 2018 9:45 AM ISTU.K. healthcare startup Cera Care has attracted more than $4 million in venture funding and amassed a roster of advisory board members that includes a...
Vertex Pharma profit tops estimates on strong launch of new CF drug Ruby Khatun Khatun28 April 2018 9:30 AM ISTVertex Pharmaceuticals Inc topped analysts’ forecasts for quarterly profit, led by stronger-than-expected sales of its latest cystic fibrosis drug as...
Zydus Cadila gets USFDA nod to market 2 drugs Ruby Khatun Khatun27 April 2018 10:45 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market two drugs used for the treatment of...
Binding bids: Fortis Healthcare board to meet again today Ruby Khatun Khatun27 April 2018 10:32 AM ISTNew Delhi: A meeting of Fortis Healthcare board yesterday remained inconclusive on the binding bids by the likes of Malaysian firm IHH Healthcare,...
Cabinet approves MoU with BRICS nations for regulation of medical products for human use Ruby Khatun Khatun27 April 2018 10:00 AM ISTNew Delhi: The government gave its nod to the signing of a pact with medicine regulatory agencies of BRICS nations on cooperation in the field of...
Novartis digital drive continues with eye-disease app Ruby Khatun Khatun27 April 2018 9:45 AM ISTZURICH: Novartis’s foray into digital technology intensified as the Swiss drugmaker launched a mobile-phone based app to help collect data from people...
US court upholds dismissal of 200 million dollars Merck verdict against Gilead Ruby Khatun Khatun27 April 2018 9:30 AM ISTA U.S. appeals court affirmed a ruling that pharmaceutical company Merck & Co dishonestly obtained patent rights and was not entitled to collect a...
